The Association of G9a Protein and Outcome of Patients With Endometrial Cancer

Far Eastern Memorial Hospital

Status: Completed

Conditions: Outcome of Endometrial Cancer

Treatments: Other: no drug

Study type: Interventional

Funder types: Other

Identifiers

NCT01271764

099095-E

Details and patient eligibility

About

Tumor invasion and metastasis are the major causes of cancer-related death. Some studies have found that histone methyltransferases, such as EZH2, specifically affect metastasis in breast, gastric and prostate cancer. The functional roles of other members of the HMT family such as G9a in cancer remain obscure. Therefore, the investigators will investigate whether G9a have a role in recurrence/metastasis of endometrial cancer.

Enrollment: 97 patients

Sex: Female

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• all cases with endometrial cancer underwent staging operation

Exclusion criteria

• nil

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

97 participants in 1 patient group

endometrial cancer

No Intervention group

Treatment:

Other: no drug